Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Everolimus MeSH Descriptor Data 2026


MeSH Heading
Everolimus
Tree Number(s)
D02.540.505.760.500
Unique ID
D000068338
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068338
Scope Note
A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.
Entry Term(s)
40-O-(2-hydroxyethyl)-rapamycin
Afinitor
Certican
RAD 001
RAD001
SDZ RAD
SDZ-RAD
Zortress
Pharm Action
Immunosuppressive Agents
MTOR Inhibitors
Registry Numbers
9HW64Q8G6G
0
Public MeSH Note
2016; EVEROLIMUS was indexed under SIROLIMUS 1998-2015; and under POLYENES 1997-1998
History Note
2016 (1997)
Date Introduced
2016/01/01
Last Updated
2022/07/14
Everolimus Preferred
RAD 001 Narrower
Certican Narrower
Afinitor Narrower
Zortress Narrower
page delivered in 0.129s